These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33438535)
1. Anticancer Natural Products with Collateral Sensitivity: A Review. Qian J; Cui J; Li S; Chen J; Jia J Mini Rev Med Chem; 2021; 21(12):1465-1486. PubMed ID: 33438535 [TBL] [Abstract][Full Text] [Related]
2. Marine Natural Products as Models to Circumvent Multidrug Resistance. Long S; Sousa E; Kijjoa A; Pinto MM Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665 [TBL] [Abstract][Full Text] [Related]
3. Natural Products Targeting Cancer Stem Cells: A Revisit. Cui J; Qian J; Chow LM; Jia J Curr Med Chem; 2021 Oct; 28(33):6773-6804. PubMed ID: 33820513 [TBL] [Abstract][Full Text] [Related]
4. MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion. Lorendeau D; Dury L; Nasr R; Boumendjel A; Teodori E; Gutschow M; Falson P; Di Pietro A; Baubichon-Cortay H Curr Med Chem; 2017; 24(12):1186-1213. PubMed ID: 27855620 [TBL] [Abstract][Full Text] [Related]
5. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558 [TBL] [Abstract][Full Text] [Related]
6. Collateral sensitivity of natural products in drug-resistant cancer cells. Efferth T; Saeed MEM; Kadioglu O; Seo EJ; Shirooie S; Mbaveng AT; Nabavi SM; Kuete V Biotechnol Adv; 2020; 38():107342. PubMed ID: 30708024 [TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines. Kars MD; Işeri OD; Gunduz U; Molnar J Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226 [TBL] [Abstract][Full Text] [Related]
8. Natural products hybrids: 3,5,4'-Trimethoxystilbene-5,6,7-trimethoxyflavone chimeric analogs as potential cytotoxic agents against diverse human cancer cells. Hassan AHE; Choi E; Yoon YM; Lee KW; Yoo SY; Cho MC; Yang JS; Kim HI; Hong JY; Shin JS; Chung KS; Lee JH; Lee KT; Lee YS Eur J Med Chem; 2019 Jan; 161():559-580. PubMed ID: 30396104 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity Relationship Studies of New Marine Anticancer Agents and their Synthetic Analogues. Fedorov SN; Stonik VA; Honecker F; Dyshlovoy SA Curr Med Chem; 2017; 24(42):4779-4799. PubMed ID: 27903218 [TBL] [Abstract][Full Text] [Related]
11. Natural products as multidrug resistance modulators in cancer. Kumar A; Jaitak V Eur J Med Chem; 2019 Aug; 176():268-291. PubMed ID: 31103904 [TBL] [Abstract][Full Text] [Related]
12. Natural quinazolinones: From a treasure house to promising anticancer leads. Li H; Fu G; Zhong W Eur J Med Chem; 2023 Jan; 245(Pt 1):114915. PubMed ID: 36375335 [TBL] [Abstract][Full Text] [Related]
13. Recent studies on natural products as anticancer agents. Ravelo AG; Estévez-Braun A; Chávez-Orellana H; Pérez-Sacau E; Mesa-Siverio D Curr Top Med Chem; 2004; 4(2):241-65. PubMed ID: 14754457 [TBL] [Abstract][Full Text] [Related]
14. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship. Qing ZX; Huang JL; Yang XY; Liu JH; Cao HL; Xiang F; Cheng P; Zeng JG Curr Med Chem; 2018; 25(38):5088-5114. PubMed ID: 28933285 [TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationships of 8-Hydroxyquinoline-Derived Mannich Bases with Tertiary Amines Targeting Multidrug-Resistant Cancer. Pape VFS; Palkó R; Tóth S; Szabó MJ; Sessler J; Dormán G; Enyedy ÉA; Soós T; Szatmári I; Szakács G J Med Chem; 2022 Jun; 65(11):7729-7745. PubMed ID: 35613553 [TBL] [Abstract][Full Text] [Related]
17. Virtual Screening of Natural Products to Select Compounds with Potential Anticancer Activity. Cavalcanti ÉBVS; Félix MB; Scotti L; Scotti MT Anticancer Agents Med Chem; 2019; 19(2):154-171. PubMed ID: 30451120 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. Pape VF; Tóth S; Füredi A; Szebényi K; Lovrics A; Szabó P; Wiese M; Szakács G Eur J Med Chem; 2016 Jul; 117():335-54. PubMed ID: 27161177 [TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities. Yang M; Liu H; Zhang Y; Wang X; Xu Z Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464 [TBL] [Abstract][Full Text] [Related]
20. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends. Saha SK; Khuda-Bukhsh AR Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]